Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451

Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451

AD is a progressive neurodegenerative disorder that is associated with the accumulation of two different insoluble protein aggregates, Aβ plaques and hyperphosphorylated tau. This study aimed to investigate the optimal acquisition and quantification of [18F]AV45 and [18F]AV1451 to image Aβ and tau,...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Firouzian, A, Whittington, A, Searle, G, Koychev, I, Zamboni, G, Lovestone, S, Gunn, R
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	SpringerOpen 2018

Gelijkaardige items

Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451
door: Azadeh Firouzian, et al.
Gepubliceerd in: (2018-03-01)

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
door: Niklas Mattsson, et al.
Gepubliceerd in: (2017-07-01)

An updated radiosynthesis of [18F]AV1451 for tau PET imaging
door: Andrew V. Mossine, et al.
Gepubliceerd in: (2017-06-01)

18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
door: Richard M. Tsai, et al.
Gepubliceerd in: (2019-01-01)

Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data
door: Suzanne L. Baker, et al.
Gepubliceerd in: (2017-12-01)

Deep learning application for the classification of Alzheimer’s disease using 18F-flortaucipir (AV-1451) tau positron emission tomography
door: Sang Won Park, et al.
Gepubliceerd in: (2023-05-01)

Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [18F]-AV-1451 PET data
door: Christina B. Young, et al.
Gepubliceerd in: (2021-11-01)

Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case
door: Marta Marquié, et al.
Gepubliceerd in: (2017-10-01)

Evaluation of the early-phase [18F]AV45 PET as an optimal surrogate of [18F]FDG PET in ageing and Alzheimer’s clinical syndrome
door: Matthieu Vanhoutte, et al.
Gepubliceerd in: (2021-01-01)

Uptake of 18F-AV45 in the Putamen Provides Additional Insights into Alzheimer’s Disease beyond the Cortex
door: Zhengshi Yang, et al.
Gepubliceerd in: (2024-01-01)

Optimization of Automatic Synthesis and Separation of [18F] AV-45 and Quality Control
door: Qi-Zhou Zhang, et al.
Gepubliceerd in: (2022-04-01)

Automated Synthesis of 18F-AV45 for Aβ-Amyloid Imaging and its Preliminary Clinical Application
door: HUANG Zhenghai;REN Chao;ZHU Shikun;WANG Xuezhu;WU Meiqi;HUO Li
Gepubliceerd in: (2021-08-01)

A simulation study on the impact of the blood flow-dependent component in [18F]AV45 SUVR in Alzheimer's disease.
door: Julie Ottoy, et al.
Gepubliceerd in: (2017-01-01)

Brain network alterations in individuals with and without mild cognitive impairment: parallel independent component analysis of AV1451 and AV45 positron emission tomography
door: Yuan Li, et al.
Gepubliceerd in: (2019-06-01)

PET tau and amyloid-β burden in mild Alzheimer's disease: divergent relationship with age, cognition and cerebrospinal fluid biomarkers
door: Koychev, I, et al.
Gepubliceerd in: (2017)

Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population.
door: Kuo-Lun Huang, et al.
Gepubliceerd in: (2013-01-01)

The Pattern of Brain Amyloid Load in Posterior Cortical Atrophy Using 18F-AV45: Is Amyloid the Principal Actor in the Disease
door: Emilie Beaufils, et al.
Gepubliceerd in: (2014-11-01)

Visual reading for [18F]Florzolotau ([18F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
door: Huan-Chun Lin, et al.
Gepubliceerd in: (2023-05-01)

In vivo imaging of tau deposition in Alzheimer’s disease using both [18F]-THK5317 and [18F]-S16: A pilot human study
door: Liping Fu, et al.
Gepubliceerd in: (2022-08-01)

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study
door: Antoinette O’Connor, et al.
Gepubliceerd in: (2023-05-01)

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
door: Tessa Timmers, et al.
Gepubliceerd in: (2019-07-01)

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease
door: Edmond Teng, et al.
Gepubliceerd in: (2021-12-01)

First-in-human study of D6-[18F]FP-(+)-DTBZ, a novel VMAT2 tracer: whole-body biodistribution and brain PET comparison with [18F]FP-(+)-DTBZ (AV-133)
door: Ruiyue Zhao, et al.
Gepubliceerd in: (2024-10-01)

18F-APN-1607 Tau Positron Emission Tomography Imaging for Evaluating Disease Progression in Alzheimer’s Disease
door: Xiaojun Xu, et al.
Gepubliceerd in: (2022-02-01)

Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [18F]Flortaucipir PET
door: Shannon L. Risacher, et al.
Gepubliceerd in: (2018-10-01)

Multicenter <sup>18</sup>F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer’s Disease
door: Michael Rullmann, et al.
Gepubliceerd in: (2022-03-01)

CSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson's Disease-A Preliminary Report.
door: Rui Gao, et al.
Gepubliceerd in: (2016-01-01)

PET imaging a MPTP-induced mouse model of Parkinson's disease using the fluoropropyl-dihydrotetrabenazine analog [18F]-DTBZ (AV-133).
door: James S Toomey, et al.
Gepubliceerd in: (2012-01-01)

En kvalitativ studie av sykepleiestudenters opplevelser av nye læringsaktiviteter i kritisk vurdering av kvantitative forskningsartikler
door: Cecilie Katrine Utheim Grønvik, et al.
Gepubliceerd in: (2015-01-01)

Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result
door: Westwood, S, et al.
Gepubliceerd in: (2018)

Integrated 18F-T807 Tau PET, Structural MRI, and Plasma Tau in Tauopathy Neurodegenerative Disorders
door: Cheng-Hsuan Li, et al.
Gepubliceerd in: (2021-03-01)

Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography.
door: Aiko Ishiki, et al.
Gepubliceerd in: (2015-01-01)

Biodistribution and Dosimetry Evaluation for a Novel Tau Tracer [18F]-S16 in Healthy Volunteers and Its Application in Assessment of Tau Pathology in Alzheimer’s Disease
door: Ying Wang, et al.
Gepubliceerd in: (2022-02-01)

Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort
door: Matteo Tonietto, et al.
Gepubliceerd in: (2024-11-01)

[18F]Tosyl fluoride as a versatile [18F]fluoride source for the preparation of 18F-labeled radiopharmaceuticals
door: Dong Zhou, et al.
Gepubliceerd in: (2023-02-01)

Tau pathology in early Alzheimer's disease is linked to selective disruptions in neurophysiological network dynamics
door: Kocagoncu, E, et al.
Gepubliceerd in: (2020)

18F-MK-6240 tau PET in patients at-risk for chronic traumatic encephalopathy
door: Michael L. Alosco, et al.
Gepubliceerd in: (2025-02-01)

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
door: Sarah Westwood, et al.
Gepubliceerd in: (2018-12-01)

TMSOTf assisted synthesis of 2'-deoxy-2'-[18F]fluoro-β-D-arabinofuranosylcytosine ([18F]FAC).
door: Kishore K Gangangari, et al.
Gepubliceerd in: (2018-01-01)

Optimizing the radiosynthesis of 6-[F-18]FDOPA using [F-18]Selectfluor
door: Forsback, S, et al.
Gepubliceerd in: (2013)